EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Delving Into Retinoblastoma Genetics: Discovery of Novel Mutations and Their Clinical Impact: Retrospective Cohort Study

Mohammad Faranoush, Masood Naseripour, Pooya Faranoush iD, Zeinab Davoodi-Moghaddam, Alireza Jahandideh, Negin Sadighnia, Delbar Daneshjou, Parisa Shams, Ahad Sedaghat, Reza Mirshahi, Shirin Ravanbod, Farzaneh Nasirnejad und 2 weitere

Cancer Medicine · 2025-05 · 14 (9)

DOI: 10.1002/cam4.70922 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Cancer Medicine, online erschienen am 02.05.2025. Verfasst von Mohammad Faranoush und 13 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Growth and Development Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Retinoblastoma, Retinoblastoma Binding Proteins, Retinal Neoplasms, Germ-Line Mutation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Retinoblastoma (Rb) is a rare intraocular malignancy that originates in the retina of children under 5 years of age. Approximately one‐third of children diagnosed with retinoblastoma are associated with germline mutations in one of the RB1 alleles. In this study, we aim to identify RB1 mutations in retinoblastoma patients using Sanger sequencing in combination with multiplex ligation‐dependent probe amplification (MLPA).

Method

The genomic DNA of 167 Rb patients was isolated from peripheral blood and their clinical information was extracted from medical records. The mutations in the RB1 gene were identified through PCR sequencing. Negative results from the PCR sequencing were further analyzed using MLPA reactions.

Results

RB1 mutations were identified in 56 of the 167 (33.5%) patients. The common mutation types were frameshift mutations ( n = 19), followed by nonsense ( n = 20), splicing ( n = 8), missense ( n = 5), and whole exon deletion ( n = 2). The overall survival rate was 98.2%, with an average follow‐up duration of 59 months. Moreover, germline RB1 mutation's correlation with enucleation rates is less pronounced in unilateral cases (12.1%) compared to bilateral cases (65.5%). A total of 13 novel mutations have been identified, of which four are specifically associated with enucleation.

Conclusion

This study provides a comprehensive analysis of RB1 germline mutations in a group of cases with Rb, leading to the identification of 13 novel mutations in Rb patients at a referral center in Iran. We expect that our findings will yield valuable insights to inform the management and genetic counseling of Rb patients, as well as their relatives who are at a higher risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RetinoblastomaRetinoblastoma Binding ProteinsRetinal NeoplasmsGerm-Line MutationUbiquitin-Protein LigasesMutationHumansMaleFemaleRetrospective StudiesInfantChild, PreschoolDNA Mutational Analysis

Stichwörter der Autor:innen

MLPARB1enucleationmutationsretinoblastoma

Substanzen

Retinoblastoma Binding ProteinsRB1 protein, humanUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Pediatric Growth and Development Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
  • Eye Research Center, The Five Senses Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Iranian Hemophilia and Thrombophilia Association (MAHTA), Tehran, Iran.
  • Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Clinical Science, Faculty of Specialized Veterinary Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran.
  • Cell and Developmental Biology Department, Faculty of Sciences and Advanced Technologies in Biology, University of Science and Culture, ACECR, Tehran, Iran.

ORCID-Profile: Pooya Faranoush, Davood Bashash

Zitieren

APA

Faranoush, M., Naseripour, M., Faranoush, P., Davoodi-Moghaddam, Z., Jahandideh, A., Sadighnia, N., Daneshjou, D., Shams, P., Sedaghat, A., Mirshahi, R., Ravanbod, S., Nasirnejad, F., Elahinia, A., & Bashash, D. (2025). Delving Into Retinoblastoma Genetics: Discovery of Novel Mutations and Their Clinical Impact: Retrospective Cohort Study. Cancer Medicine, 14(9). https://doi.org/10.1002/cam4.70922

Vancouver

Faranoush M, Naseripour M, Faranoush P, Davoodi-Moghaddam Z, Jahandideh A, Sadighnia N, et al. Delving Into Retinoblastoma Genetics: Discovery of Novel Mutations and Their Clinical Impact: Retrospective Cohort Study. Cancer Medicine. 2025;14(9). doi:10.1002/cam4.70922

BibTeX
@article{Faranoush2025,
  author = {Faranoush, Mohammad and Naseripour, Masood and Faranoush, Pooya and Davoodi-Moghaddam, Zeinab and Jahandideh, Alireza and Sadighnia, Negin and Daneshjou, Delbar and Shams, Parisa and Sedaghat, Ahad and Mirshahi, Reza and Ravanbod, Shirin and Nasirnejad, Farzaneh and Elahinia, Ali and Bashash, Davood},
  title = {Delving Into Retinoblastoma Genetics: Discovery of Novel Mutations and Their Clinical Impact: Retrospective Cohort Study},
  journal = {Cancer Medicine},
  year = {2025},
  volume = {14},
  number = {9},
  doi = {10.1002/cam4.70922}
}
Kostenlos starten →